1,033 results on '"Tsushima T"'
Search Results
52. Molecular characterization of mulberry small circular RNA: a new species with a nature of satellite RNA showing hammerhead and new hairpin-like ribozyme activity
53. 1772P - Prevalence of venous thromboembolism based on intensive screening for patients with advanced solid tumor in prospective observational study
54. Faraday Rotation in [Co.sup.3+]-Substituted Magnetic Garnets
55. Risk factors for esophageal fistula in esophageal squamous cell carcinoma invading adjacent organs (T4b) treated with definitive chemoradiotherapy
56. 61. Evaluation of the regional lymph node for cervical esophageal squamous cell carcinoma: Proposed selection for improved survival stratification
57. Regnase-1 N-terminal domain
58. Regnase-1 Zinc finger domain
59. Crystal structure of Regnase PIN domain, form I
60. Regnase-1 C-terminal domain
61. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma
62. 394P A self-controlled trial of prophylactic topical application of vitamin K1 cream for cetuximab-related skin rash
63. 165P Neutropenia as a predictive factor in patients with metastatic colorectal cancer treated with TAS-102
64. 191P Comparison of neoadjuvant chemotherapy followed by surgery (NAC) with adjuvant chemotherapy following surgery (ADJ), and NAC with definitive chemoradiotherapy for locally advanced esophageal cancer patients
65. The role of neoadjuvant or adjuvant chemotherapy for invasive bladder cancer: Is there a benefit for survival or preserving the bladder?
66. 1111P - Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer
67. 511P - Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases (CLM): A post hoc analysis of the WJOG4407G phase III study
68. Solubilization of insulin binding and degrading activity from guinea pig kidneys
69. Graves’ disease with neutropenia and marked splenomegaly: autoimmune neutropenia due to propylthiouracil
70. Insulin autoimmune syndrome with insulin-resistant diabetes at the incipient stage prior to hypoglycemic attacks
71. Isolation of clones from T24 cells and test of their sensitivity to adriamycin
72. Immunoprecipitation of 125I-insulin crosslinked receptor
73. Measurement and comparison of individual external doses of high-school students living in Japan, France, Poland and Belarus—the ‘D-shuttle’ project—
74. 365 Identification of the recommended phase II dose (RP2D) of the c-Met Inhibitor tepotinib (MSC2156119J) in Japanese patients (pts) with solid tumors: A phase I trial
75. 1616 A double blind, self-controlled randomized trial of prophylactic topical vitamin K1 cream application for cetuximab-related skin toxicity (VANQUISH trial)
76. 2168 Predictive biomarker analysis of early tumor shrinkage induced by FOLFIRI+Bev for patients with metastatic colorectal cancer in WJOG4407G study
77. 2116 A multicenter phase I/II study of TAS-102 with bevacizumab for metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE)
78. 2301 Phase 2 study of Nivolumab (Anti-PD-1; ONO-4538) in Patients with Esophageal Cancer: Preliminary Report
79. First report of Coleus blumei viroid 5 infection in vegetatively propagated clonal coleus cv. ‘Aurora black cherry’ in Japan
80. PD-017 A multicenter phase I/II study of TAS-102 with bevacizumab for metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE)
81. First report of Dahlia latent viroid and Potato spindle tuber viroid mixed‐infection in commercial ornamental dahlia in Japan
82. LBA17 - Anti-CC-chemokine receptor 4 (CCR4) antibody mogamulizumab (Moga) and nivolumab (Nivo) combination phase I study in patients with advanced or metastatic solid tumors
83. 516P - A Multicentre Phase I/II Study of TAS-102 with nintedanib in patients with metastatic colorectal cancer refractory to standard therapies (N-task force: EPOC1410)
84. 639P - A phase II study of TAS-102 for advanced/recurrent esophageal cancer refractory/intolerable to standard therapies
85. 638P - Two year survival and safety update for esophageal squamous cell carcinoma treated with nivolumab (ATTRACTION-01/ONO-4538-07)
86. Receptor-Stimulated System Mediated Interactions of Neuropeptides in GH3 Cells
87. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
88. Hall effect and magnetoresistance in Fe1-xCuxCr2S4.
89. Annealing effects on magnetic properties of amorphous GdCo, GdFe, and GdCoMo films.
90. Spin-dependent phonon Raman scattering and electronic structure of CdCr2X4 (X:S,Se).
91. Effect of in-plane field on the stripe end motion in LPE-garnet films.
92. Coercive force in heat-treated R-Co alloys.
93. Phase I Clinical Trial of Ds-7423, an Oral Pi3K/Mtor Dual Inhibitor, in Japanese Patients with Advanced Solid Tumors
94. Clinicopathological Features and Outcomes of Gastric Cancer Patients with Pulmonary Lymphangitis Carcinomatosa
95. [Congenital esophagobronchial fistula treated with thoracoscopic assisted surgery]
96. Spin-Structure Determination in Single Crystals of Some Chromites.
97. 668P - Risk factors for esophageal fistula in esophageal squamous cell carcinoma invading adjacent organs (T4b) treated with definitive chemoradiotherapy
98. Effective phase control of silicon films during high-rate deposition in atmospheric-pressure very high-frequency plasma: Impacts of gas residence time on the performance of bottom-gate thin film transistors
99. Outcome of Anti-Egfr Antibody Therapy in Metastatic Colorectal Cancer with Low-Frequency Kras Mutations
100. Efficacy and Safety of Gemcitabine Plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.